[Diabetic ketoacidosis and hypofibrinogenemia as a complication of the treatment with L-asparaginase of acute lymphoblastic leukemia].
D001215:Asparaginase / Q000009:adverse effects*; D002648:Child; D016883:Diabetic Ketoacidosis / Q000139:chemically induced* / Q000188:drug therapy; D005260:Female; D005340:Fibrinogen / Q000097:blood*; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D007945:Leukemia, Lymphoid / Q000188:drug therapy*
D007328:Insulin; D005340:Fibrinogen; D001215:Asparaginase
Cetoacidosis diabética e hipofibrinogenemia como complicación del tratamiento con L-Asparaginasa de la leucemia linfoblástica aguda.